EAM
HALO icon

Empirical Asset Management’s Halozyme HALO Stock Holding History

Empirical Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,810
Closed -$186K – 366
2024
Q4 		$186K Buy
+22,810
New +$1.17M 0.06% 312

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Empirical Asset Management's HALO Position: Q1 2025 in Review

Empirical Asset Management sold out of Halozyme (HALO) in Q1 2025, closing a stake of 22,810 shares — an estimated $186K sold.

Empirical Asset Management first reported a position in HALO in Q4 2024 and held it in 1 quarter. The position peaked at $186K in Q4 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Empirical Asset Management reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Empirical Asset Management sold 22,810 Halozyme shares in Q1 2025, an estimated $186K.
  • Empirical Asset Management first reported a position in Halozyme in Q4 2024 and held it in 1 quarter.
  • Empirical Asset Management's Halozyme position peaked at $186K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Empirical Asset Management's 13F filing for Q1 2025, filed 12 May 2025.